Speciality: Oncology
Description:
Welcome to this insightful discussion featuring Dr. Vamshi Krishna M, a renowned expert in oncology, as he delves into the unmet needs and challenges in the current care of ALK-positive Non-Small Cell Lung Cancer (NSCLC). In this video, Dr. Vamshi highlights the significant gaps in treatment options, including resistance mechanisms, limited access to next-generation therapies, and the need for personalized approaches to improve patient outcomes. He emphasizes the importance of early detection, advanced diagnostics, and the development of novel therapeutic strategies to address these pressing issues.
Dr. Vamshi further explores the real-world challenges faced by clinicians managing ALK-positive NSCLC, such as treatment sequencing, managing side effects, and optimizing therapy for better survival rates. He discusses the evolving landscape of targeted therapies and immunotherapy while underscoring the necessity for more clinical trials and collaborative research to bridge existing gaps. His expertise provides valuable perspectives for oncologists, researchers, and healthcare professionals striving to enhance patient care in this niche yet critical area of lung cancer.
Don’t miss this compelling discussion that sheds light on the future directions and unmet needs in ALK-positive NSCLC. Stay tuned for more expert insights from Dr. Vamshi Krishna M and other leading voices in oncology. Be sure to watch till the end and subscribe for updates on upcoming videos that continue to explore groundbreaking advancements in cancer care.
See More Webinars @ Hidoc Webinars
1.
Headlines About Doc Who 'Catches' Patient's Cancer Are Popping Up Again
2.
Loneliness and social isolation linked to heightened risk of death in those with cancer
3.
Induction Immunotherapy Has Durable Survival Benefit in LACC
4.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
5.
Elder Abuse: Red Flags to Look Out For While Receiving Care.
1.
Personalized Cancer Vaccines and Neoantigen mRNA: A New Era in Oncology
2.
Methemoglobinemia in OR & ICU: Pathophysiology, Detection, and Management Review
3.
Uncovering the Hidden Picture: Using Ultrasound to Diagnose Breast Cancer
4.
Intrapancreatic Fat, Pancreatitis, and Cancer: Role of Cancer-Associated Fibroblasts
5.
Unlocking the Mystery of Ovarian Cancer Staging
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I
2.
Navigating the Complexities of Ph Negative ALL - Part XI
3.
Navigating the Complexities of Ph Negative ALL - Part VIII
4.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation